,

Recombinant Vaccinia virus Myristoylated protein G9 (VACWR087), partial

Recombinant Vaccinia virus Myristoylated protein G9 (VACWR087), partial — Component of the entry fusion complex (EFC), which consists of 11 proteins. Purity >90%.

SKU: BCRECP-004707 Categories: ,

Product Specifications

Product SkuBCRECP-004707
Product DescriptionRecombinant Vaccinia virus Myristoylated protein G9 (VACWR087) Protein is expressed from Yeast with C-terminal 6xHis-tagged. It contains 2-319aa. [Accession | P07611].
Uniprot No.P07611
Gene NamesVACWR087
PurityGreater than 90% as determined by SDS-PAGE.
Expression SystemYeast
Expression Region2-319aa
SpeciesVaccinia virus (strain Western Reserve) (VACV) (Vaccinia virus (strain WR))
Tag InfoC-terminal 6xHis-tagged
Molecular weight37.8kDa
ActivityPlease contact us to obtain bioactivity data.
BufferIf the delivery form is liquid, the default storage buffer is Tris/PBS-based buffer, 5%-50% glycerol. If the delivery form is lyophilized powder, the buffer before lyophilization is Tris/PBS-based buffer, 6% Trehalose.
StorageStore at -20°C/-80°C upon receipt, aliquoting is necessary for mutiple use. Avoid repeated freeze-thaw cycles.
Research AreasOthers

Function

Component of the entry fusion complex (EFC), which consists of 11 proteins. During cell infection, this complex mediates entry of the virion core into the host cytoplasm by a two-step mechanism consisting of lipid mixing of the viral and cellular membranes and subsequent pore formation.

Product Specifications

Recombinant Vaccinia virus Myristoylated protein G9 (VACWR087), partial is a recombinant protein, expressed in Yeast, covering amino acids 2-319aa, with C-terminal 6xHis-tagged tag, molecular weight 37.8kDa, purity Greater than 90% as determined by SDS-PAGE.. Suitable for ELISA and Western Blot applications.

Recommended applications depend on the target, product format, and product-specific validation data. Refer to the product datasheet or Certificate of Analysis (CoA), or contact BioCrest Sci for application guidance.

Biological Activity: Please contact us to obtain bioactivity data.

Storage: Store at -20°C/-80°C upon receipt, aliquoting is necessary for mutiple use. Avoid repeated freeze-thaw cycles.

Shipping & Lead Time: Availability, shipping conditions, and estimated lead time are confirmed in the formal quotation or order confirmation based on the product format, destination, and order requirements.

Protein Biology

Function

Component of the entry fusion complex (EFC), which consists of 11 proteins. During cell infection, this complex mediates entry of the virion core into the host cytoplasm by a two-step mechanism consisting of lipid mixing of the viral and cellular membranes and subsequent pore formation

Gene: OPG094  |  Organism: Vaccinia virus (strain Western Reserve)

Frequently Asked Questions

How do I order or inquire about this product?

Submit the Online Inquiry form with your required quantity and specifications, or email sales@biocrestsci.com. Available sizes, pricing, stock status, documentation, and estimated lead time are confirmed in the formal quotation.

What is the shipping and delivery time?

Availability, dispatch timing, shipping conditions, and delivery estimates depend on the product format, destination, and order requirements. These details are confirmed in the formal quotation or order confirmation.

How should this product be stored?

Follow the storage and handling instructions in the product-specific datasheet and Certificate of Analysis (CoA). Requirements may vary by product form and formulation; contact BioCrest Sci if product-specific guidance is needed.

What quality controls are performed on your products?

Quality-control data such as identity, purity, endotoxin level, or biological activity are provided only when specified on this product page, the datasheet, or Certificate of Analysis (CoA). Biological activity is not implied unless explicitly stated.

Shopping Cart
Scroll to Top